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1. Introduction 
Erectile dysfunction (ED) is defined as the consistent or recurrent inability of a man to attain 
and/or maintain penile erection sufficient for sexual activity. According to current 
guidelines, a 3-month symptom duration is accepted to establish the diagnosis except for 
some cases of trauma or surgically induced ED (Lewis R 2010).  ED affects physical and 
psychosocial health and has a significant impact on the quality of life (QoL) of sufferers and 
their partners and families. Epidemiologic studies for ED estimate the prevalence of ED 
ranging between 20-30 % among men aged between 40-80 years (Laumannn et al 2005, 
Lewis R 2010). These differences in reported incidences are probably due to variations in the 
methodology and the age and socioeconomic status of the study populations. 
ED is a disorder in which subjective perception of patients is very important, therefore, the 
aim of the treatment should not only be organ focused but also be patient-outcome oriented. 
Patient satisfaction with sexual intercourse, their overall sex lives and ED treatments may 
represent reliable predictors of key patient-related treatment outcomes, in addition to 
pharmacological efficacy and safety (Carson C, et al. 2004) 
The basic diagnostic work-up for patients who presented with ED should include a 
thorough medical and psychosexual history to identify common causes and risk factors of 
ED and assess psychological status of patients by using validated instruments 
(Hatzimouratidis K, et al. 2010). A focused physical examination should be the next step to 
evaluate possible penile deformities, prostatic diseases, signs of hypogonadism, 
cardiovascular and neurological status of the patients. Evaluation of serum glucose, lipid 
and testosterone levels is also an essential part of the initial evaluation of ED patients.  
Patients suffering from ED should be treated with a structured strategy which may be 
influenced by efficacy, safety, invasiveness, cost effectivity and satisfaction of both the 
patient and his partner. These parameters should also be considered for the selection of the 
treatment option for each particular patient and his partner.    
Although newer medical treatment alternatives such as PDE-5 inhibitors, vacuum erection 
devices and intracavernosal applications are considered first and second lines of ED 
therapy, respectively; surgical treatment, especially penile prosthesis implantation, is the 
standard of care in cases of medication-resistant ED. Surgical treatment options in order to 
correct ED are divided into three categories. These categories are: 
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1. Penile prosthesis implantation 
2. Penile revascularization 
3. Surgery for corporal veno-occlusive dysfunction 
2. Penile prosthesis implantation 
From the historical point of view, the wooden sticks that were either placed under the skin 
of the penis or into the urethra are known as the earliest implanted materials designed to 
improve erectile function (Henry GD, 2009). With increased knowledge of human anatomy, 
autologous materials were started to be implanted. The first real attempt to create an 
internal penile support and provide penile rigidity was described in 1936 by Bogoras who 
used a piece of cartilage as a penile stiffener in a total phallic reconstruction (Bogoras 1936). 
This is followed by Beheri who first documented successful intracavernosal placement of 
polyethylene rods in 700 patients in 1966 (Beheri 1966). The successful implantation of a new 
semirigid silicone cylinder that fulfills the whole corpora was described in 1973 which lead 
to the development of new implants that are currently used(Scott 1973). 
2.1 Indications of surgery 
There are many types of penile prosthesis designs that are currently available for 
implantation, but it should be kept in mind that not all patients with ED are candidates for 
penile prosthesis implantation. Implantation of penile prosthesis is indicated for the 
treatment of organic ED in men who fail or reject more conservative measures, such as oral 
PDE5 inhibitors, vacuum erection devices (VED), urethral alprostadil suppositories, and 
intracavernosal injection therapy. Additionally, implants are appropriate when medical 
therapy is contraindicated, cause severe side effects, vacuum erection therapy has proven 
unsatisfactory or unacceptable, and/or in men with end organ failure (e.g. diabetes 
mellitus), severe structural abnormalities (e.g. Peyronie’s disease), cavernosal fibrosis (e.g. 
after prolonged priapism or infection). Patients who experience ED after radical 
prostatectomy or pelvic organ transplantation may also serve as the candidates for penile 
prosthesis implantation. Careful counseling before penile implant procedures will reduce 
the probability of problems that may result in postoperative dissatisfaction. The type of the 
prosthesis for each particular patient should be selected according to the patients’ needs and 
expectations (Carson CC 2005). Patients at younger age with normal manual dexterity or 
who wear firm clothing often choose a three-piece inflatable penile prosthesis because 
appearance in the flaccid position is better than other designs (Hellstrom WG, et al. 2010). In 
addition, inflatable penile prosthesis should be the preferred option in patients with 
Peyronie’s disease, history of previous implantation procedures or neurological disorders 
where considering interior tissue pressures are declined between uses and the risk of 
extrusion is diminished (Zermann DH, 2006).  For some patients such as paraplegics, 
malleable prostheses can be chosen since inflatable ones have much higher malfunction 
rates. Malleable penile prosthesis can be better served in those patients who lack adequate 
manual dexterity, or those with significant obesity (Hellstrom WG, et al. 2010). 
2.2 Types of implants  
There are three classes of penile implants including hydraulic, semi-rigid and soft silicone. 
The hydraulic implants consist of two types, the three-piece inflatable and the two-piece 
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inflatable. The only two-piece device currently available is AMS Ambicor(Fig.1). When this 
nondistensible device is deflated, the cylinders collapse and the penis, unlike that with a 
malleable prosthesis, is not rigid. When the scrotal pump is cycled, a small volume of fluid 
is transferred from the rear tips of the cylinders into the distal nondistensible chambers 
filling and then pressurizing them. Different from 3-piece inflatable prosthesis, Ambicor 
does not increase in size with inflation. Flaccidity and erection are more compromised with 
this model when compared with 3-piece device due to low, restricted reservoir volume. Also 
the device is not available with antibiotic impregnated forms as of yet, but has an acceptable 
short-term mechanical reliability (Levine LA 2001).  
 
Fig. 1. AMS Ambicor two-piece inflatable penile prosthesis 
The ideal penile prosthesis would produce flaccidity and erection that mimics natural 
condition. Three-piece inflatable prostheses provide these conditions by transferring fluid 
into and out of cylinders. These devices consist of a pair of cylinders, reservoir and a pump. 
AMS and Coloplast are the two main companies that manufacture 3-piece inflatable 
prostheses. Coloplast manufactures the Titan Inflatable Penile Prosthesis (Fig. 2) and the Titan 
Narrowbase Inflatable Penile Prosthesis. The Narrowbase implant is developed for patients 
with small penises or for cases in which dilation is limited because of scarring from corporal 
fibrosis or previous surgery. All of these cylinders expand in girth, but not in length. AMS 
manufactures the AMS 700 CX Inflatable Penile Prosthesis (Fig. 3), the AMS 700 LGX Inflatable 
Penile Prosthesis, and the AMS 700 CXR Inflatable Penile Prosthesis. The CXR device, like the 
Titan Narrow-base prosthesis, has smaller diameter cylinders and is used in revision cases and 
less commonly in men with small penises.  
Apart from other devices, AMS LGX cylinder has a unique property that it expands both in 
girth and length (Fig 4). The CX and CXR have a unidirectional weave that allows only girth 
expansion, whereas the LGX has a bidirectional weave permitting expansion both in length 
and girth. In patients with organic ED and penile deformity or curvature, girth only 
expanding devices may provide better cosmetic outcome. In men with small penises or men 
with scarring due to ischemic priapism or previous penile surgery where corporeal dilation 
is limited, smaller diameter CXR cylinders often serve as a better alternative. 
Infections are known to be the most significant and unwanted complications in IPP surgery, 
especially for revision/replacement, which may develop due to decreased host resistance,  
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Fig. 2. Hydrophilic-coated Coloplast Titan™ threepiece prosthesis with reservoir lock-out 
valve to minimize autoinflation  
 
Fig. 3. AMS 700 CX inflatable penile prosthesis  
 
Fig. 4. AMS LGX inflatable penile prosthesis   
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impaired antibiotic penetration due to capsule formation, and decreased wound healing 
related to scarring. Most bacteria produce a mucin coat or biofilm that is the bacterial 
colonisation over the device and resistant to systemic antibiotic treatment due to decreased 
metabolic needs (Silverstein A, et al 2003). Antibiotics or the body’s defense mechanisms can 
not eradicate the bacteria inside the biofilm without removing all prosthetic components 
and irrigation of the implant spaces (Stewart et al 2001). Both manufacturers developed 
advances in the designs of prosthesis in order to decrease the incidence of infections by 
applying coatings to the prosthesis designed to retard bacterial growth. In 2001, AMS 
introduced InhibiZone™ (Fig. 5) which is a patented antibiotic surface treatment that 
impregnates minocycline and rifampin into the external silicone surfaces of all the 
components, except the RTE, giving the orange-like color.  
 
Fig. 5. AMS 700 MS™ series cylinder with Inhibizone® antibiotic surface treatment. AMS = 
American Medical Systems. 
The antibiotics reach into the implant space within 10 days. They seem effective in the 
prevention of bacterial colonization and development of biofilm layer (Nickel JC, et al.1998). 
Minocycline and rifampin may help decrease the probability of developing bacterial 
resistance by inhibition of protein synthesis and inhibition of DNA-dependent RNA 
polymerase, respectively (Darouiche RO, et al 1999). In-vitro and in-vivo studies have 
demonstrated the effectiveness of minocycline in retarding the emergence of staphylococcal 
strains that are resistant to rifampin (Raad et al 1995). Short-term follow-up for this 
prosthesis enhancement shows statistical improvement in infection reduction for first time 
implant patients by a single surgeon (Wilson SK, et al 2002). Coloplast also produced 
antibiotic-coated devices named as Titan and Titan NB. The hydrophilic coating absorbs 
much more water and the idea is the adherence of antibiotics to the surface of prosthesis 
when soaked into antibiotic solutions.  
It should be remembered that pumping systems of inflatable devices require some manual 
dexterity and patients who lack this ability may experience difficulties in order to make 
these devices work. AMS developed Momentary Squeeze Pump (MSP) that contains a much 
smaller pump with the inflation part in the most dependent site and deflation part in the 
upper portion of pump. It delivers more volume per squeeze and is easier to find deflation 
button. The main difference with the previous pump is that the MSP deflates completely 
after pressing the deflation button for a few moments. It also has a lock-out valve precluding 
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auto-inflation of the implant. Early clinical studies reported significant reduction in time 
spent instructing the patient in use of this device (Henry GD, et al 2004). 
Semi-rigid rod prostheses are constructed of two solid prostheses that are independently 
placed in each corpus cavernosum(Sadeghi-Nejad H 2007). They are divided into two types 
as the malleable and the mechanical. Coloplast’s Genesis is a malleable device that consists 
of a braided silver wire surrounded by a silicone hydrophilic coat. The AMS 650 and 600 
implants have similar construction of silicone surrounding a stainless steel woven core.  Soft 
silicone rods were originally manufactured in France by Subrini (Subrini L 1982). They are 
ideal for patients in whom the cosmetic advantages of the inflatable devices are not as 
important as the ease of use and the lower chances of mechanical failure in semirigid 
implants. Pelvic organ transplant recipients may be well served by the semirigid devices 
rather than a three-piece inflatable device due to the results of a study addressing the higher 
incidence of reservoir complications in the retroperitoneal space (Cuellar DC, 2001). The 
narrow cylinders are appropriate for thin penises and for the penises with scar tissue where 
dilation to a large caliber corporal body is not easily performed. 
Implantation of three-piece inflatable prostheses is a complex issue since they require a 
reservoir which has a large volume to be placed in the abdominal cavity. Since reservoir has 
a high capacity, complications such as stretching of pliant tunica and compression of erectile 
tissue that cause deterioration of the erectile tissue with time which are observed with the 
use of self-contained or two-piece devices with no reserve fluid volume are not seen in 
three-piece inflatable implants (Wilson SK, et al 1996). The three-piece inflatable also gives 
the best flaccidity, as all fluid can be drained out of the cylinders into the reservoir when the 
non-erect state is desired. Satisfaction rates of 70–87% are reported from patients after 
appropriate consultation. 
2.3 Patient selection 
The surgeon has three choices when selecting a prosthesis for a particular patient which 
include semirigid, two-piece inflatable, and three-piece inflatable prosthesis. Generally, the 
decision of the type of the prosthesis to be used depends on the physician’s comfort with the 
surgical approach, assessment of body habitus, penile size, previous abdominal surgery and 
manual dexterity of the patient. Recently, the 3-piece inflatable prosthesis is accepted as the 
gold standard option in industrialized countries. 
The semi-rigid rods are easy to implant and manipulate since they are bendable and can 
easily be maneuvered (Hellstrom WG et al, 2010). This kind of implants may have tendency 
to be eroded through glans because of cylinder pressure and loss of sensation in patients 
with spinal cord injury. Implantation of inflatable prostheses in this patient population can 
be recommended even if the implant is used only to make condom catheter urinary 
drainage easier (Rossier 1984). 
Two-piece inflatable devices have the advantage of avoiding intra-abdominal reservoir 
placement. They provide better functional outcomes than rod implants in terms of rigidity 
and flaccidity. 
Although three-piece inflatable devices provide the best rigidity, it should be beneficial to 
use these devices in patients with a larger penis. Similarly, patients with shorter penises 
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mostly prefer three-piece devices because of the difficulty to hide semi-rigid rods and two-
piece implants. Semi-rigid rods are generally selected in patients with limited manual 
dexterity or those who experience problems with the use of hydraulic devices. A motivated 
partner who may manipulate the device will be an exception to this issue. 
Penile prosthesis implantation restores penetrative ability, however, it has no effect on 
recovery of sexual drive, glandular sensitivity and ejaculatory functions. If the removal of 
implants occurs at a later date, the capsule remains and the empty space will partially fill 
with proliferating scar tissue which makes it difficult for the patient to respond sufficiently 
to other medical treatment alternatives. Therefore, it is important that the patient should be 
aware of his expectations about the penile prosthesis. Also, a detailed discussion between 
surgeon and patient about the outcomes and potential complications of the procedure such 
as infection which may necessiate reoperation with a rate of 1-4% and mechanical 
dysfunction should be performed (Govier et al 1998, Wilson et al 1999). 
2.4 Preoperative preparation and postoperative care 
Preoperative preparation of patient aims to reduce the risk of infection (AUA Guidelines 
2005). Lower urinary tract should be investigated before prosthetic surgery to find out some 
abnormalities such as urinary tract infection and urethral stricture. A urinalysis, 
determination of post-void residual urine, and cystoscopy in indicated cases should be 
performed in order to rule out these abnormalities. If infection is detected, it should be 
treated or the patient should be placed on prophylactic antibiotic treatment before the 
surgery. Any obstruction that may be due to prostatic hypertrophy or bladder neck 
contracture should be treated prior to prosthetic surgery. Simultaneous insertion of penile 
prosthesis and artificial urinary sphincter may be recommended in patients who suffer from 
urinary incontinence after radical prostatectomy. Although there are some studies which 
reported that a better control of blood sugar in patients with diabetes mellitus is associated 
with a lower risk of infection, larger studies detected no difference in infection rates in 
normal or elevated blood glucose level (Wilson SK, et al 1998). More recently, Mulcahy et al 
reported the results of 6071 diabetic patients who underwent penile prosthesis implantation 
with antibiotic (minocycline and rifampin) impregnated and 624 patients implanted with 
non-antibiotic impregnated implants with initial revision rates of 1.47% and 4.17%, 
respectively(Mulcahy et al 2011). At the end of 7 year-follow-up, authors found out the rate 
of infection related revisions significantly lower for antibiotic impregnated implant (1.62%) 
than for nonimpregnated implants (4.24%). It is also determined that diabetic men had a 
significantly higher rate of revisions due to infection at 7 yr (1.88%) than men without 
diabetes (1.53%). Finally, authors concluded that this long-term evidence obtained from the 
largest patient population establishes that the use of an antibiotic-impregnated IPP can 
decrease revisions due to infection and this decline may represent a significant medical 
advance in erectile restoration for diabetic patient population. There are a few measures to 
decrease the risk of infection such as showering with antibacterial soap, shaving operation 
area and use of broad-spectrum antibiotics one hour prior to surgery. Insertion of a catheter 
may facilitate urethral dissection and provide space for reservoir placement by emptying the 
bladder if a scrotal incision is carried out. The catheter may remain until the following 
morning. Some surgeons have tendency to use drains at the end of the surgery to reduce 
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edema and provide an exit for bleeding. Such a drain is removed the following morning and 
has not demonstrated an increased incidence of prosthesis infection (Wilson SK, et al 1996). 
Most patients need oral pain medication following the surgery. Heavy exercise and other 
activities which may cause displacement of the reservoir into the inguinal canal are 
proscribed for 4 weeks. Patients are instructed to use the device and return the sexual 
activity at the postoperative period of 4 to 6 weeks (Montague DK. 2011). Since initial 
inflation of the prosthesis may be difficult to perform; it will be beneficial to instruct the 
patients to inflate and deflate the device twice daily for the first month after surgery.  
2.5 Operative technique 
There are a variety of approaches for the implantation of penile prostheses described in the 
literature. These are distal penile, infrapubic and penoscrotal approaches. The distal penile 
approach is generally preferred for insertion of a semirigid or malleable penile prosthesis. 
Better visualization for the reservoir placement is the advantage of infrapubic approach. 
However, neurovascular injury which may result in decreased distal penile sensation is 
more likely due to close relationship with neurovascular bundle. Two-piece devices, due to 
the absence of a separate reservoir, are best implanted through a penoscrotal incision. 
Infrapubic approach may be preferred in patients with the history of previous abdominal 
surgeries where reservoir placement is complicated, however, penoscrotal approach 
provides ease in massive obese patients. In conclusion, the approach chosen for each 
particular patient should be based upon the type of prosthesis available, anatomy and 
surgical history of patient and preference of the surgeon. 
2.5.1 Distal penile approach 
This approach is generally accepted as the best approach for insertion of a semirigid or 
malleable penile prosthesis. It provides some advantages such as well incision healing, 
allowing corporeal dilation, and facilitation of rod placement. 
After placement of a foley catheter, a circumcoronal incision is carried out and dissection is 
performed down to the layer of Buck’s fascia with special consideration to prevent harm to 
dorsal penile nerves, which course within Buck’s fascia. After identification of Buck’s fascia, 
stay sutures are placed in the two corpora through the tunica albuginea lateral to the penile 
nerves. Dilation of corpora is performed by large scissors to establish a track in the corporal 
tissue. Dilation then follows with Hegar or Brooks dilators from 9 to 14 depending upon 
required cylinder girth. Once the corpora are measured by using a Furlow or other dilator, 
the cylinders can be placed. The corporotomy is then closed with 2-0 absorbable, synthetic 
sutures. With noninflatable cylinders, a penile block can be performed and a 
noncompression dressing is applied. 
2.5.2 Infrapubic approach 
The infrapubic approach is carried out by a horizontal or vertical incision approximately one 
finger below the symphysis pubis. After performing incision, subcutaneous tissue is 
dissected down to the rectus fascia. The rectus fascia is then incised and dissected for 
approximately 2 to 3 cm. A midline separation of the rectus muscles is achieved by sharp 
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and blunt dissection to create a pouch beneath the rectus muscles in order to insert the 
reservoir without any discomfort. Dissection is then carried out over the corpora cavernosa. 
Sharp and blunt dissection is performed on either side of the fundiform ligament, 
identifying the dorsal neurovascular bundle. At this point, it should be remembered that the 
dorsal nerves of the penis lie approximately 2 to 3 mm lateral to the deep dorsal vein. Once 
Buck’s fascia has been dissected free from the tunica albuginea, the shiny white tunica 
albuginea is fixed with longitudinal traction sutures. Then, a corporotomy incision is 
performed between the traction sutures. Following corporotomy, scissors are used to initiate 
the tunneling of the corpora cavernosa. Hegar dilators from size 9 to 14 can also be used. If 
corporeal fibrosis is encountered, Rossillo cavernotomes can be used to dilate to size 12. 
After performing dilation bilaterally, Furlow introducer can be used to measure corporal 
length by using the traction suture as the reference point.  
Proximal and distal measurements are added to give total corporal length and choose 
appropriately sized inflatable cylinders. A length slightly less than the total measurement is 
usually used to permit comfortable positioning of the cylinders. Rear tip extenders of size 
0.5, 1, 2, 3 cm, or combinations thereof are placed on the proximal cylinder end to adjust 
length. 
Following measurement, interrupted sutures can be placed for subsequent corporotomy 
closure. When the corporotomy sutures are placed, cylinders are positioned in the dilated 
corpora cavernosa using the Furlow inserting tool with distal needle to pull the cylinders 
into position. It is important to ensure that adequate positioning of proximal and distal ends 
of cylinders has been performed. The corporal incision should be placed proximal enough to 
allow easy exit of the input tube and minimize cylinder/input tube contact. Closure of the 
corpora cavernosa is carried out with traction on the cylinder placement suture to maintain 
it in a flat, nonkinking position and ensure adequate seating. Following placement of 
cylinders and closure of the corporotomy incision, cylinder inflation can be tested by 
pumping fluid to identify any abnormalities in position, curvature, or related problems. A 
finger is placed beneath Scarpa’s fascia down into the scrotum on one side to develop a sub 
dartos pouch for the pump. The pump is then positioned in the most dependent portion of 
the scrotum. The reservoir is then placed into the previously prepared area and filled with 
saline. Before connection, it is important to release pressure on the filling syringe and 
determine if any backfilling is observed. This backfilling or backpressure may predict an 
autoinflation problem in the future. Tubing connection is then carried out using quick 
connectors or suture tie plastic connectors. The tubing is tailored to eliminate excessive 
length but to allow for adequate pump positioning. Shodded clamps are used to compress 
the ends of tubes. Following tailoring, tubes are irrigated to eliminate small particles or 
blood clots. After the tubing is connected, the adequacy of the connection is tested by gently 
pulling on the connectors. All shodded clamps are removed and the device is inflated and 
deflated on multiple occasions to ensure adequate location, placement, and erection. 
After that, thorough irrigation with antibiotic solution and then closure of rectus fascia with 
interrupted sutures are carried out. The wound then is closed in the standard fashion with 
two layers of subcutaneous tissue and a subcuticular skin suture leaving the cylinders 
partially inflated for 24 hours to improve haemostasis. A dry, sterile dressing is applied and 
a foley catheter is placed at the end of the procedure. Suction drains may be used according 
to surgeon’s preference. The catheter is usually removed in the first postoperative day. The 
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cylinders are deflated and patient discharged after the removal of drain. At discharge, 
patients are prescribed with a one-week antibiotic regimen and instructed to start cycling 
the device. Sexual activity can usually be resumed 6 weeks postoperatively (Garaffa G, et al 
2010).  
2.5.3 Penoscrotal approach 
Three-piece inflatable penile prostheses, as well as semirigid and two-piece prostheses can 
be implanted by a transverse or vertical penoscrotal incision. This approach has distinct 
advantages in obese patients and is the most common approach for routine penile prosthesis 
implantation. Since differentiation of corpus spongiosum and corpus cavernosum is 
mandatory during dissection in this approach, initial insertion of a foley catheter is 
generally recommended. The incision is placed in the upper portion of the scrotum one 
finger below the penoscrotal junction. Once the skin incision has been carried out, dissection 
is continued lateral to the corpus spongiosum and urethra to expose the corpora cavernosa. 
Incision, dilation, and closure of the corpora cavernosa are similar to that described 
previously for the infrapubic incision, but synthetic absorbable sutures should be used with 
this approach because the suture line may be palpable postoperatively. Cylinder sizing and 
placement are as described above. Pump placement is likewise in the most dependent 
portion of the scrotum just below the dartos fascia. Dissection for reservoir placements can 
be carried out with a second separate infrapubic incision, but is more commonly performed 
through the penoscrotal incision. The scrotal skin incision is retracted to the area of the 
external inguinal ring and dissection is carried out medial to the spermatic cord. It is 
important to drain the bladder completely at this point. The transversalis fascia is then 
identified and incised sharply using large scissors pushed firmly through the medial aspect 
of the external inguinal ring. Dilation is carried out with the index finger after incision of the 
transversalis fascia. The reservoir balloon is then positioned over the index finger and 
placed in the perivesical space. Inflation of the reservoir is carried out with care that no 
backpressure is observed. Pocket enlargement should be performed to prevent autoinflation 
in case of syringe refilling. Once the reservoir is placed, inflated, and tubing connected as 
previously described, the device is tested in inflation and deflation modes. Closure is carried 
out with a subcuticular suture in the standard fashion. 
2.6 Complications of penile prosthesis implantation  
Complications of penile prosthesis can be divided into two categories as intraoperative and 
postoperative complications. Intraoperative complications include corporal cross-over and 
corporal/urethral perforation. Corporal cross-over can be subdivided into proximal and 
distal and might be encountered during corporal dilatation or cylinder placement (Garaffa 
et al 2010). This complication may be easily detected and corrected during the procedure. 
Testing for cross over is performed by side by side placement of dilators in each corpus 
cavernosum with special consideration to symmetry and proper positioning. If a crossover  
is detected, the dilator may be simply redirected with the contralateral dilator left in situ  
to prevent repeat crossover. Corporal perforation may also be recognized and easily 
repaired during the procedure, however, if urethral perforation is suspected, the procedure 
should be abandoned to allow for spontaneous recovery of the tear or a direct repair 
through a separate incision should be performed while the cylinder is in place. 
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Postoperative complications include infection, mechanical failure, auto-inflation, glans 
tumescence or coolness, reservoir displacement, cylinder erosion or extrusion and 
cavernosal fibrosis. 
The two main complications of penile prosthesis implantation are mechanical failure and 
infection. Mechanical failure of penile prosthesis can include leakage from the cylinders, 
tubing fracture, reservoir malfunction, connector disruption, tube kinking and cylinder 
aneurysm. Historically, mechanical failure rates have been known to be low with many 
studies reporting rates of failure between 5-15% (Milbank et al 2002, Deuk et al 2001, Daitch 
et al 2001). Although, mechanical failure rates are low, manufacturers provided some 
improvements in the design of prostheses to achieve more successful outcomes. Five year 
freedom from mechanical failure rates reached over 90% after these improvements. More 
recently, Dhar et al. reported the long-term results of 455 patients who underwent penile 
prosthesis implantation with AMS 700 CX and found out that the overall freedom from 
reoperation was 74.9% and from mechanical failure was 81.3% after ten years (Dhar NB, et 
al 2006).  A large-scale study performed with 2384 patients who had undergone penile 
prosthesis implantation with four different implant types reported revision-free survivals 
for all reasons to be 68.5% at 10 years and 59.7% at 15 years. For freedom from mechanical 
failure, the results were 79.4% at 10 years and 71.2% at 15 years (Wilson SK, et al. 2007). In 
another recently published, long-term study, Kim et al. reported the mechanical reliability 
results of AMS 700CX/CXM in 397 men with mean age of 63.1 years and follow-up duration 
of 113 months (Kim et al 2010). Mechanical survival rates of the prostheses were 97.6%, 
93.2% and 78.2% at 3, 5, and 10 years after implantation, respectively. It is also reported that 
the overall survival of implants were significantly lower in patients with neurogenic ED 
when compared to non-neurogenic ones which may be due to decreased glandular 
sensation and difficulty in having natural position during sexual intercourse. 
Infection is the bane of penile prosthesis surgery because, if it occurs in the space around the 
implant, total removal of all prosthetic material will be needed. Penile prosthesis 
reimplantation is more difficult due to corporal fibrosis in these patients. 
A number of measures have been taken to decrease the risk of infection in prosthesis 
implanted patients. The most popular approach to reduce the rate of infection is the 
impregnation of antibiotics to the surface of prosthetic devices. Initial research suggests 
these newer interventions decrease the rate of prosthetic infection. With antibiotic 
prophylaxis, the infection rate is 2–3% and may be further reduced by using an antibiotic 
impregnated or hydrophilic-coated implant. Recently, Carson et al. reported the results of 
the retrospective comparison of the initial revision events due to infection in patients who 
underwent antibiotic impregnated or non-impregnated implantation with a follow-up of 7.7 
years. At the end of follow-up, it is determined that initial revision rates due to infection 
were significantly lower in the impregnated group (Carson CC 2011). In another study, the 
antimicrobial activity of InhibiZone-coated IPPs produced by AMS was compared with the 
Titan hydrophilic-coated implants (produced by Coloplast) dipped in vancomycin, in both in-
vivo and in-vitro animal models (Mansouri MD, et al 2009). The antimicrobial activity of the 
two implants was also compared against a control. In-vivo zones of inhibition were compared 
for each group against methicillin-resistant Staphylococcus aureus (MRSA), methicillin-
resistant S. epidermidis (MRSE), vancomycin-resistant Enterococcus (VRE), and Escherichia 
coli. It is found that the InhibiZone-treated implants produced a larger zone of inhibition 
www.intechopen.com
 
Erectile Dysfunction – Disease-Associated Mechanisms and Novel Insights into Therapy 
 
172 
against MRSA, VRE, and E. Coli when compared with the vancomycin-dipped Titan implant 
and control and zones of inhibition were equivalent for MRSE in both implants. Similar results 
were obtained in animal models. Authors concluded that InhibiZone prostheses have a 
broader spectrum in vitro and a more durable antimicrobial activity in vitro and in an animal 
model than implants dipped in vancomycin. Therefore, the use of InhibiZone implants may 
help reduce the incidence of penile implant infection.  
The use of prophylactic broad spectrum antibiotics is widespread in penile prosthetic 
surgery; however, the timing of the administration of these antibiotics varies among 
different studies. According to the guidelines “infusion of the first antimicrobial dose should 
begin within 60 minutes before surgical incision and that prophylactic antimicrobials should 
be discontinued within 24 hours after the end of surgery”. It is well-known that infection 
rates in revision penile prosthetic surgery have been higher than primary implant surgery. 
During the revision surgery, the entire device is removed and the implant spaces are 
lavaged with multiple antiseptic solutions before implantation of a new device, the infection 
rate is similar to that with first time (primary) penile prosthesis implantation (Henry GD, et 
al 2005). Mulcahy et al. reported an 82% success rate achieved by using salvage therapy 
which involves removal and reimplantation immediately following thorough irrigation of 
the corpora with a multiantibiotic solution (Mulcahy et al 1996). More recently, the success 
rate increased to 84% in 101 patients who had infected implants (Mulcahy et al 2003). The 
salvage protocol described by Mulcahy should be performed in a stepwise fashion which 
consists of the removal of all prosthetic parts and foreign material, irrigation of wound and 
all compartments with 7 antiseptic solutions, changing operative equipment such as gloves, 
drapes and implantation of new prosthesis, closing the wound primarily without any drain 
and prescribe oral antibiotics according to culture for one month. The 7 antiseptic solution 
contains kanamycin and bacitracin, half strength hydrogen peroxide, half strength povidone 
iodine, water pic pressure irrigation with 1 gm vancomycin and 80 mg gentamicin in 5 liters, 
half strength povidone iodine, half strength hydrogen peroxide, kanamycin and bacitracin.  
Autoinflation of a three-piece device may cause discomfort for the patient. In a study, the 
rate of autoinflation was reported between 3-5% (Hollenbeck BK et al 2002).  
In order to prevent auto-inflation, Mentor developed a lockout valve mechanism that is 
added to prosthetic reservoir stem. This mechanism decreased the risk of autoinflation by 
transferring the fluid from reservoir in response to negative pressure from the pump 
(Wilson SK, et al 2002). Autoinflation risk decreased to the rate of 1.3% after this 
modification. 
Coloplast developed Coloplast Titan One-Touch Release (OTR) pump to make device 
deflation easier for the patient. The new OTR pump allows cylinder deflation with one firm 
squeeze to the release pads. One firm squeeze of these pads causes the deflate valve to shift 
into the open position, providing a new pathway for fluid flow from the cylinders to the 
reservoir. In a recent study, Shaw et al assessed the functionality and surgeon experience 
with 100 consecutive patients implanted with a Titan OTR pump, compared with 100 prior 
consecutive patients implanted with a Titan Genesis pump (Shaw et al.2011). At the end of a 
mean length of follow-up of 20.8 months in the Genesis group and 8.4 months in the OTR 
group, the average number of postoperative teaching sessions needed to teach the patient 
how to operate the device was significantly lower in the OTR group (1.87 vs. 1.19). It is also 
reported that no pump malfunctions were seen in either group and the OTR pump was 
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subjectively easier for the surgeon and the patient to deflate when compared with the 
Genesis pump.  
Reservoir complications are not commonly encountered, however, they include herniation 
into inguinal canal and upper scrotum or erosion into adjacent viscera. Reservoir herniation 
is a rare complication that occurs in approximately 0.7% of three-piece inflatable prosthesis 
surgery cases (Sadeghi-Nejad et al. 2001). This complication is exclusively limited to cases 
when the penoscrotal approach is used. It may be caused by vigorous postoperative 
coughing or failure of proper initial reservoir placement under the transversalis fascia. 
Reservoir protrusion through an unrecognized existing hernia or a large tranversalis defect 
created intraoperatively are other possible contributory factors. Decreased spontaneous 
autoinflation of the cylinders in the immediate postoperative period may result in a lower 
incidence of this adverse event. Correction of this complication is by revision through an 
inguinal incision with placement of the reservoir in its proper position and repairing the 
defect (Hellstrom WG, et al.2010). 
Some patients may suffer from poor support of the glans by the tips of the prosthesis. This 
angulation of the glans penis is called as the supersonic transport (SST) deformity because of 
the similarity of its appearance to the supersonic transport of aircraft. This deformity may 
develop secondary to small-size prosthesis or incomplete distal dilation of the corpora. If the 
problem occurs during the operation, following the achievement of adequate distal dilation, 
a larger rear-tip extender may be placed to lengthen the cylinder and see whether the defect 
is corrected. If the problem is noted in the immediate postoperative period, it is wise to wait 
a few weeks and allow for complete healing and scar formation, which may result in glans 
fixation and resolution of the SST deformity (Carson C. 1999)  
Device extrusion may develop as an isolated finding or may be a sign of the device infection. 
Semirigid prosthesis are more prone to erosion, as the rate was reported as 18.1% for 
semirigid prostheses, 2.4% for self contained inflatable and 0% for 3-piece inflatable ones 
(Zermann et al 2006). Distal cylinder extrusion can be corrected by preparing a new cavity 
for the distal cylinder behind the back wall of the fibrotic sheath containing it (Mulcahy JJ. 
1999). An alternative technique is to perform distal corporoplasty using synthetic material. 
Proximal perforation of the crura during the implant procedure can be repaired by the 
constructing wind sock of vascular prosthetic material and anchoring this to the prosthesis. 
More recently, Shindel et al described a novel technique of transglanular repair of the 
impending distal erosion of penile prostheses and reported successful outcomes in 4 of 6 
patients during the follow-up (Shindel et al. 2010).   
2.7 Outcomes of penile prosthesis surgery 
Different from other treatments of ED, inflatable prostheses allow men to achieve a rigid 
erection on demand and as often as desired and also allow them to maintain the erection for 
a long period of time. Men with ED may develop performance anxiety and loss of 
confidence in their sexual capabilities, however, implantation of penile prosthesis may 
restore both erectile capacity and men’s sexual confidence and provides the best results 
among all ED treatment modalities in terms of satisfaction. 
In a study performed with 138 ED patients, the satisfaction rates were found to be 
significantly higher in patients treated with penile prosthesis implantation when compared 
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with patients treated with sildenafil and intracavernous prostoglandin E1(Rajpurkar et al 
2003). There are various studies that reported high satisfaction rates for both patients and 
partners after penile prosthesis implantation for the treatment of ED. Montorsi et al reported 
the results of 200 consecutive patients who underwent prosthetic surgery with 3-piece 
inflatable implants and reported a 98% patient and 96% partner satisfaction rate. Authors 
noted that the major factors that contribute to these high satisfaction rates are the rapid 
ability of the implants to produce an erection and consistent excellent rigidity (Montorsi et 
al 2000). However, loss of penile length which is likely to occur in revision surgeries after 
infection or penile shortening in Peyronie’s disease may result in much lower satisfaction 
rates (Montorsi et al 1996).   
There are many factors that may influence the patient satisfaction, such as postoperative 
pain and edema, occurrence of postoperative complications, cosmetic outcome, functional 
integrity of the device, ability to use and partner acceptance. Apart from these factors, 
reduced sensitivity, diminished sexual drive, unnatural feeling and perception of having a 
diminished role in initiating erection by the partner may be accepted as the other reasons of 
dissatisfaction. In a study performed by Akin-Olugbade et al over 114 penile prosthesis 
recipients, all patients showed significant improvement in IIEF and EDITS scores, however, 
patients with Peyronie’s disease, body mass index over 30 and who underwent radical 
prostatectomy had lower satisfaction rates than the overall group. It should be kept in mind 
that these men have shorter penile length and failure of the implants to restore this length 
loss may contribute to increased rate of dissatisfaction (Akin-Olugbade et al 2008). High 
complication rates and unrealistic expectations are the other reasons of this low satisfaction 
rate.  
More recently, Natali et al reported the results of 200 patients who underwent penile 
prosthesis implantation with AMS 700 CX, AMS Ambicor and AMS 600-650 with a mean 
follow-up of 5 years and found out a patient satisfaction rate of 97%, 81% and 75%, 
respectively (Natali et al 2008). In the same study, partner satisfaction rate was reported as 
92%,91% and 75%, respectively. In another case series, 41 of 42(97.6%) patients reported 
successful intersourse after penile prosthesis implantation (Xuan XJ et al 2007). Paranhos et 
al reported the outcomes of 139 patients who underwent penile prosthesis implantation 
with a mean follow-up of 40 months (Paranhos et al 2010). The overall satisfaction rate was 
86.3% for patients and 83.4% for partners at the end of the follow-up. In a recently 
performed study, Bettocchi et al evaluated 80 patients who underwent prosthesis surgery 
and reported that seventy-six patients (97%) affirmed to use penile prostheses frequently. 
Fifty-four patients (69%) and 70 partners (90%) affirmed that they never had problems with 
the use of the prosthesis and they considered themselves satisfied. Outcomes of these 
studies of penile prosthesis implantation concerning patient and partner satisfaction are 
summarized in table-1. 
3. Penile arterial revascularization   
Penile microarterial bypass surgery which was first described by Michal, is considered as a 
milestone in the treatment of ED because it is accepted as the only treatment option that is 
capable of restoring normal erectile function without the need of using any external 
mechanical (vacuum erection) devices, vasoactive medications or surgical placement of  
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Author  Year of 
publication 











2000 200 98% 91% AMS 3-piece 
implant 






















2010 80 97% 90% AMS 700 CX 
Table 1. Outcomes of the penile prosthesis procedures 
penile prosthesis (Michal 1973). The objective of the surgery is to bypass arterial lesions that 
cause obstruction in the hypogastric-cavernous arterial bed (Hellstrom WJ, et al. 2010). 
Specifically, this surgery aims to increase the cavernosal arterial perfusion pressure and 
blood inflow in patients with vasculogenic ED that is developed due to pure arterial 
insufficiency. Lack of standardization in patient selection, hemodynamic evaluation and 
surgical technique as well as limited long-term outcome data using validated instruments 
have resulted in this surgery being considered by many surgeons as an experimental 
procedure. However, guidelines recommended that this type of surgery is proposed only to 
men with recently acquired ED secondary to focal arterial lesions and with the evidence of 
no existing generalized vascular disease. Additionally long operation time and the 
requirement for microsurgical expertise resulted in less frequent use of penile 
revascularization procedures. The efficacy of this surgery is still controversial and not 
evidence-based, largely because the selection criteria, outcome measurements, and 
microsurgical techniques have not been objective or standardized.  The patients who are 
candidates for MABS (microarterial by-pass surgery) should fulfill some criteria such as age 
younger than 55 years with recently acquired ED due to focal occlusive disease of the 
common penile or cavernosal arteries detected by penile Doppler ultrasound, 
cavernosometry and selective internal pudendal arteriography. The patients who have 
vascular risk factors (diabetes, hypertension, tobacco use, hypercholesterolemia), evidence 
of neurological ED (eg multiple sclerosis, pelvic surgery, lumbosacral radiculopathies etc), 
nontreated hormonal abnormalities, psychiatric disorders (severe depression, bipolar 
disease, schizophrenia), Peyronie’s disease, premature ejaculation and any evidence of 
corporo-occlusive dysfunction should not be considered as a candidate for this type of 
surgery. Young men who have sustained traumatic arterial lesions appear to have better 
outcomes compared to elderly patients. 
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Historically, Michal et al who reported the first MABS, performed a direct anastomosis 
between the inferior epigastric artery (IEA) and the corpus cavernosum (Michal I) which 
provided a sufficient flow rate and intraoperative erection. However, this procedure 
resulted in anastomotic stenosis in all patients and unsatisfactory success rates. 
Consequently, they performed the anastomosis between the IEA (end-to-side) and the 
dorsal penile artery (DPA) and achieved a success rate of 56% (Michal II)( Michal et al 1980).  
Virag et al. performed the anastomosis between the IEA to the deep dorsal vein in order to 
increase penile perfusion in a retrograde fashion and reported a 49% success rate and an 
additional 20% improvement (Virag et al 1981). Furlow et al. also performed arterialization 
procedures of the dorsal vein with ligation of the circumflex branches to avoid glanular 
hyperemia, with success rates of 62% (Furlow et al 1988). Hauri reported a complicated side-
to-side anastomosis between the dorsal artery and vein covered by a spatulated IEA that 
resulted in success rates of 80% (Hauri 1984) 
MABS techniques that are currently defined include an anastomosis between the IEA to the 
dorsal vein (arterialization) or artery (revascularization). Artery-to-vein procedures are 
easier to perform than artery-to-artery, however, the failure rates are higher due to some 
reasons such as that the dorsal vein has valves that most likely impair penile reperfusion 
and may be associated with anastomotic thrombosis. Also, the use of a valvulotome may 
improve retrograde reperfusion to the corpora, but may also cause endothelial injury, which 
may activate the intrinsic pathway of the clotting system, leading to early thrombosis and 
failures. Finally, artery-to-artery MABS eliminates the possibility of penile hyperemia. 
Munarriz et al reported the long-term results of the patients who underwent MABS and 
although not supported by their data, they favor a MABS with the anostomosis between 
IEA- and the dorsal artery(Munarriz et al 2009).  
MABS has three steps which include dorsal artery dissection, IEA harvesting, and 
microsurgical anastomosis (Munarriz et al 2004).  
1. Dorsal artery dissection is performed via a 5-cm semilunar incision 2 cm below the 
penoscrotal junction. While the penis is stretched, blunt dissection is carried out along Buck’s 
fascia towards the glans to invert the penis. The fundiform ligament is identified and 
preserved to minimize penile shortening. The selected dorsal artery is isolated and mobilized 
proximally, avoiding injury of the dorsal nerves. Temporary scrotal closure is performed.  
2. Harvesting of IEA begins with a 5-cm transverse incision between umbilicus and pubis. 
Dissection is carried down through Scarpa’s fascia, the rectus fascia is divided vertically, and 
the rectus muscle mobilized medially. The IEA is identified and mobilized from its origin at 
the level of the common external iliac artery to the umbilicus. If arterial branches are found, 
they are controlled with bipolar cautery and divided. During the mobilization of the IEA, 
papaverine is utilized to prevent vasospasm. The distal end of the IEA is clipped near the 
umbilicus and divided. Subsequently, the scrotal staples are removed and a clamp is utilized 
to transfer the IEA to the dorsal aspect of the penis through the external inguinal ring. The 
abdomen is closed in a multilayer fashion using a running technique with 0 polyglycolic acid 
suture for the rectus fascia, 2-0 for Scarpa’s, and a 4-0 monocryl for the skin. 
3. Microvascular Anastomosis: The dorsal artery is mobilized and divided in a proximal 
location on the penile shaft. The proximal end is cauterized using the bipolar cautery. 
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Aneurismal clips are placed on the dorsal artery and IEA. The adventitia of the distal end of 
the IEA and proximal dorsal artery is sharply excised with microscissors to prevent 
thrombosis of the anastomosis. A microsurgical anastomosis is performed using a simple 
interrupted technique with 10-0 Nylon stitches. The dorsal aneurismal clip is removed and 
back blood flow is observed, documenting anastomotic patency. The IEA aneurismal clip is 
removed and if there is no anastomotic leak, the penis is placed back on its normal 
anatomical position, the Dartos closed with a running 2-0 polyglycolic acid suture, and the 
skin with a 4-0 polyglycolic acid suture. Patency of the anastomosis is further confirmed by 
Doppler ultrasound. 
3.1 Complications of the penile revascularization surgery 
Penile shortening and decreased penile sensitivity may be observed in up to 25% of the 
patients after the procedure (Munarriz 2010). It is thought that penile shortening is the result 
of fibrosis/scarring of the fundiform ligament and its incidence may be minimized by the 
preservation of this ligament during the procedure. Decreased penile sensation is mostly 
seen due to a denervation injury during surgery, however, patients who underwent this 
operation may still report improvement in their orgasmic function. Glans hyperemia is 
another commonly observed complication with a rate of 13% in some series (Manning M, et 
al 1998). Other less common complications are wound infection and inguinal hernia. 
3.2 Outcomes of penile revascularization surgery 
Generally, the studies reporting the results of penile revascularization surgery are 
retrospective, had small numbers of patients, short term follow-up, variable patient selection 
criteria and type of surgery. To make a standardization and proper evaluation of these 
studies published, however, AUA guidelines recommend some inclusion criteria such as 
presence of a normal serum testosterone level, failure of pharmacologic erection test, 
abnormal nocturnal penile tumescence or penile duplex Doppler ultrasonography, 
abnormal penile arteriogram, artery to artery or artery to dorsal vein anastomosis employed 
in surgical technique, objective follow-up data reported by either duplex Doppler 
ultrasonography, penile arteriogram, or validated outcome questionnaire in the absence of 
diabetes mellitus and history of smoking. Also the follow-up period of studies to be 
included should at least have a period of 12 months. There are only four studies fulfilling 
these criteria which report variable success rates with different surgical techniques (Table-2).     
Author Type of 
surgery 







Ang (1997) Dorsal vein 6 8-37(20) 66 (4) NPT,Doppler 
De Palma 
(1995) 
Dorsal artery 11 12 to 48 60% (7) Doppler 
Grasso (1992) Dorsal artery 22 12 months for all 68 (15) 36 (8) NPT, Doppler 
Jarow (1996) Mixed  11 12 to 84 (50) 91 (10) Doppler  
Munarriz 
(2010) 
Dorsal artery 71 NA(34.5) 88.7% (63) IIEF 
Table 2. Outcomes of the penile revascularization procedures 
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Apart from these studies, Kawanishi et al. reported the results of 51 men with arteriogenic 
ED who had objective outcome data reported by color Doppler duplex studies and a longer 
follow up period (Kawenishi et al 2004). The patency of the neoarterial blood flow either by 
the Hauri or Furlow-Fischer procedure was assessed objectively by color flow duplex 
Doppler. The authors reported the objective estimated efficacy rate as 84.9 % at 3 and 65.5% 
after 5 years of follow-up. 
Although guidelines do not recommend this kind of procedures in elderly people, Kayigil et 
al reported the results of deep dorsal vein arterialization (DDVA) in 43 carefully selected 
healthy elderly patients with a mean follow-up of 22 months(Kayıgil et al 2008). All patients 
underwent DDVA using the Furlow-Fisher technique. Surgical outcome was tested 
postoperatively by IIEF score. The success rate of the operation was 60.5% at the end of 
follow-up. More recently, Kayıgil et al reported the long-term results (73.2 months) of 110 
men who underwent revascularization surgery and reported an overall success rate of 
72%(Kayıgil et al 2011). The success rates were 81.8% at 3 months, 77.2% at 1 year, 70% at 2 
years, 66.3% at 3 years, and 63.6% at 5-year after surgery in the patients who achieved a no-
ED threshold score of more than 26 in the IIEF-15. Authors concluded that this procedure 
may serve as a better alternative to prosthesis surgery by using a physiological restoration 
mechanism further studies are needed to compare the outcomes of different treatment 
modalities.   
Recently, Babei reported a systematic review and metaanalysis to determine the results of 
patients with arteriogenic ED who underwent penile revascularization surgery. 
Characteristics of participants, study qualities, types of interventions, cure rates and adverse 
events were analyzed. Outcomes of procedures were found to be better in men younger 
than 30 years old and in men with the absence of venous leakage and history of smoking. In 
conclusion, the authors noted that inconsistent measurements of outcomes limited the 
findings, and none of the studies were randomized controlled trials. Authors also concluded 
that this kind of procedures may be beneficial in highly selected patients, however, 
randomized-controlled trials examining penile revascularization techniques are needed to 
recommend one technique over another (Babei et al 2009). 
Robot-assisted vessel harvesting for penile revascularization is a new surgical approach in 
patients who suffered pelvic crush injuries resulting in post-traumatic ED. Raynor et al. 
reported five patients that underwent penile revascularization using a modified Virag-V 
technique (Raynor et al.2010). The epigastric artery was harvested robotically and 
transposed through a 3 cm incision at the base of the penis. Microscopic revascularization 
was performed by anastomosing the epigastric artery to the deep dorsal vein. Distal dorsal 
vein ligation of the subcoronal plexus was performed to prevent glans hyperemia. The 
procedure was successful in 4 patients. Authors concluded that this procedure is an ideal 
minimally invasive complement to penile revascularization which may shorten operation 
time and offer a novel option for the use of minimally-invasive technology.  
4. Surgical treatment of Corporal Veno-Occlusive Dysfunction (CVOD) 
Cavernous veno-occlusive dysfunction is another type of ED which may result from 
congenital reasons or trauma in young men, and acquired factors such as Peyronie’s disease, 
diabetes mellitus and late onset hypogonadism in older men. 
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Pathophysiology of venogenic ED (VED) consists of formation of large venous channels 
draining the corpora cavernosa, degenerative changes to the tunica albuginea, structural 
alterations of the cavernous smooth muscle and endothelium (Ghanem et al 2008). Whatever 
the cause is, the objective of the treatment is to obstruct this leakage. It is found out that the 
deep dorsal vein is the major site of venous leakage in more than 75% of cases (Fuchs et 
al.1989).  
Surgical treatment for VED should be considered when medical treatment fails to provide 
sufficient erection. Selection criteria for surgery include the patients with erections of short 
duration or tumescence only with sexual stimulation; younger than 50 years; normal 
cavernous arterial inflow in response to an intracavernous injection agent; and who are 
more likely to have venous leakage after performing Doppler ultrasound or penile 
cavernosography in the absence of chronic systemic diseases (Manning M et al 1998). 
Surgery for penile venous leakage is not recommended in older men because penile venous 
leakage often results from atrophy of the intracorporeal muscles or the tunica albuginea 
(Lue TF 1999, Montague DK, et al 1996).  However, when venous leakage is congenital, the 
deficiency is usually in the large, ectopic, superficial and deep dorsal veins or the large 
crural veins (Lue TF, 1999, Ebbehoj et al. 1979). Currently, there is no evidence from 
randomized controlled trials to recommend a standardized approach for the diagnosis and 
effective treatment of veno-occlusive ED. Since it is generally accepted that venous leakage 
is an effect rather than a cause, and newer pathophysiologic mechanisms that cause CVOD 
and therapeutic possibilities that might address these causes, are being examined. Research 
continues to detect an effective surgical treatment alternative.  
Although there is no standard evidence-based surgical option, ligation of superficial dorsal 
vein, deep dorsal vein, crural vein, crural plication/ ligation, arterialization of deep dorsal 
or cavernosal veins or extraperitoneal laparoscopic penile vein ligation are some of the 
intervention types used in CVOD surgery. 
Recently, Cayan et al reported the results of a study including 26 men with a mean age of 34, 
who underwent penile venous surgery for primary venous leakage with a mean follow-up 
of 42 months (Cayan 2008). Surgical procedure consists of resection of the superficial and 
deep dorsal veins, ligation of the cavernous vein and 2 crura proximal to the entrance of the 
cavernous artery with umbilical tapes, and preservation of the dorsal artery and nerve on 
each side. In the follow-up, erectile function improved in 19 men and remained unchanged 
in 7 men. Patient satisfaction with no additional treatment or with phosphodiesterase-5 
inhibitors was 88.4% and only 3 patients were unsatisfied with the surgery. It is concluded 
that penile venous surgery with crural ligation for venous leakage has excellent long-term 
results, high patient satisfaction rate and should be offered to young men with primary 
cavernous ED. Additionally, young patients who have normal penile arterial system and no 
risk factors such as diabetes are the best candidates for the improved postoperative 
outcome. Since the surgery of ligation or resection for venous leakage has not been very 
successful and unsatisfactory long-term results have reduced the indications for venous 
surgery, a new technique which is the embedding of dorsal vein for dorsal venous leakage is 
reported to improve the long-term outcomes (Zhang et al 2009). The procedure is performed 
through a curved incision made over the root of the penis. Following the dissection of deep 
dorsal vein, a whole thickness tunica albuginea excision of about 0.8 cm was performed and 
the dissected vein is embedded to this newly formed groove. At the end of 42 months of 
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average follow-up, 14 of 17 patients reported satisfactory intercourse and three had 
sufficient erection after oral treatment. Besides, it was also noted that there were significant 
improvements in terms of IIEF-5 scores and some Doppler USG parameters in all patients. 
According to these results, authors concluded that this new surgical technique is a simple 
operation which seems to provide promising results with the need of future studies in the 
treatment of penile deep dorsal venous leakage of ED.      
Possible complications that may be encountered in the post-operative period include wound 
infection, skin necrosis, glandular hyperemia or hypoesthesia, inguinal hernia, penile 
curvature, shortening or edema. 
If CVOD surgery is going to be performed, a long-term follow-up of at least 48 months is 
recommended with the use of pre and postoperative validated scales (e.g. IIEF). Post-
operative follow-up should include objective evaluation of the penile vascular and erectile 
status. Penile color duplex ultrasound after complete cavernosal smooth muscle relaxation is 
the gold standard investigation of choice for both pre-op and post-op objective assessment. 
The type of operation offered to the patient should be determined depending on the 
experience and preference of the surgeon and the basis of the site, nature, and size of the leak. 
5. Conclusion  
Penile prosthesis implantation is currently the most effective treatment option in terms of 
both patient and partner satisfaction in the management of ED. Satisfaction rates and 
prosthesis survival significantly increased with the improvements in both prosthesis design 
and surgical techniques. Among prosthesis types, inflatable 3-piece prosthesis have the best 
outcomes and recommended for younger patients with normal manual dexterity, patients 
with Peyronie’s disease, neurological disorders, patients who underwent radical 
prostatectomy and in revision procedures. Preoperative preparation and use of antibiotic 
impregnated devices during surgery are the essential points to reduce the risk of prosthesis 
infection. The ideal prosthesis aims to mimic natural erection and flaccidity as well as 
possible and research to find the ideal prosthesis still continues. Further technological 
improvements may provide additional significant increases in satisfaction and survival rates 
and decrease the number of infected implants. Penile revascularization is not a commonly 
performed procedure and its use is limited only to selected cases because of the variabilities 
in inclusion and exclusion criteria, short length of follow-up, and lack of objective follow-up 
data. However, patients who are younger than the age of 55, non-smoker, non-diabetic with 
the absence of venous leakage may have a better outcome after the procedure. Penile venous 
surgery is not a recommended surgical treatment modality due to absence of a standardized 
surgical technique and follow-up data. This operation may only be recommended for young 
patients with site-specific congenital, posttraumatic or post-inflammatory venous leaks with 
informed consent. The type of the operation for each particular patient should be decided 
according to experience of surgeon, site, size and nature of the venous leak. 
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